132 related articles for article (PubMed ID: 21860368)
1. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.
Brusselaers N; Sadr-Azodi O; Engstrand L
J Gastroenterol; 2020 Apr; 55(4):453-461. PubMed ID: 31811561
[TBL] [Abstract][Full Text] [Related]
2. Dyspepsia, peptic ulcer disease, and esophageal reflux disease.
Schwartz MD
West J Med; 2002 Mar; 176(2):98-103. PubMed ID: 11897730
[No Abstract] [Full Text] [Related]
3. Helicobacter pylori infection and long term proton pump inhibitor therapy.
McColl KE
Gut; 2004 Jan; 53(1):5-7. PubMed ID: 14684566
[No Abstract] [Full Text] [Related]
4. Molecular mechanisms in therapy of acid-related diseases.
Shin JM; Vagin O; Munson K; Kidd M; Modlin IM; Sachs G
Cell Mol Life Sci; 2008 Jan; 65(2):264-81. PubMed ID: 17928953
[TBL] [Abstract][Full Text] [Related]
5. The changing patterns of dispensing branded and generic drugs for the treatment of gastroesophageal reflux disease between 2006 and 2011 in Japan: a retrospective cohort study.
Murata K; Hinotsu S; Hamada S; Ezoe Y; Muto M; Kawakami K
BMC Health Serv Res; 2015 Feb; 15():76. PubMed ID: 25885571
[TBL] [Abstract][Full Text] [Related]
6. The implications of the PEPTIC trial for clinical practice.
Young PJ; Bagshaw SM; Bellomo R; Nichol AD; Wright SE
Crit Care Resusc; 2020 Mar; 22(1):4-5. PubMed ID: 32102637
[No Abstract] [Full Text] [Related]
7. Prescription of proton pump inhibitors. Ulcer healing drugs affect gastroscopy results.
Ross I; Edgehill J
BMJ; 1999 Feb; 318(7182):534. PubMed ID: 10024271
[No Abstract] [Full Text] [Related]
8. Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score-Matched Study Using UK Biobank.
Fan X; Liu Z; Miyata T; Dasarathy S; Rotroff DM; Wu X; Poulsen KL; Nagy LE
Gastroenterology; 2021 Jan; 160(1):455-458.e5. PubMed ID: 32980342
[No Abstract] [Full Text] [Related]
9. Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
Ghebremariam YT; Lee JC; LePendu P; Erlanson DA; Slaviero A; Shah NH; Leiper JM; Cooke JP
Circulation; 2014 Apr; 129(13):e428. PubMed ID: 24687654
[No Abstract] [Full Text] [Related]
10. Reducing the use of proton pump inhibitors in infants with reflux symptoms.
Størdal K; Ma A; Beck CE
BMJ; 2024 May; 385():e074588. PubMed ID: 38816024
[No Abstract] [Full Text] [Related]
11. [Omeprazole for everybody?].
Sánchez DP; Guillén JJ; Torres AM; Sánchez FI
Aten Primaria; 2014; 46(6):315-6. PubMed ID: 24697916
[No Abstract] [Full Text] [Related]
12. Drugs for GERD and peptic ulcer disease.
Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
[No Abstract] [Full Text] [Related]
13. Comparison table: Drugs for GERD and peptic ulcer disease.
Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
[No Abstract] [Full Text] [Related]
14. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
Paikka N
Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
[TBL] [Abstract][Full Text] [Related]
15. [Effect of acid suppression in subjects with Helicobacter pylori infection].
Fujisawa T; Adachi K; Kinoshita Y
Nihon Rinsho; 2005 Nov; 63 Suppl 11():387-90. PubMed ID: 16363565
[No Abstract] [Full Text] [Related]
16. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
17. Drugs for peptic ulcer disease and GERD.
Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
